$HYH (Halyard Health, Inc.)

$HYH {{ '2016-04-11T23:33:23+0000' | timeago}} • Announcement

$HYH said that it has agreed to acquire Buffalo Grove, Illinois-based CORPAK MedSystems for $174MM. The all-cash transaction will be funded with a combination of current cash and $HYH's revolving credit facility. The transaction is expected to close in the second quarter.

$TFX {{ '2017-07-24T12:12:24+0000' | timeago}} • Announcement

$TFX said its Arrow Seldinger Arterial Catheterization Device received market clearance from the U.S. Food and Drug Administration (FDA). The new Seldinger Arterial Catheterization Device is indicated for short-term use. $TFX expects to launch the Arrow Seldinger Arterial Catheterization Device in US this year.

$ABT {{ '2017-07-20T19:55:45+0000' | timeago}} • Webcast

For 3Q17, $ABT expects adjusted EPS of $0.64-0.66, with operational sales growth expected in the mid-single digits. At current exchange rates, the company expects operational sales growth to have a negative YoY impact of around 0.5%.

$ABT {{ '2017-07-20T19:45:56+0000' | timeago}} • Webcast

$ABT said that on a comparable operational basis, 3Q17 Established Pharmaceuticals sales growth is expected in the high double-digit, while in Nutrition, sales growth is expected in low single-digit. In Diagnostics, $ABT expects sales to increase mid-to-high single digits and in Medical Devices, sales is expected to increase double-digits.

$ABT {{ '2017-07-20T17:49:19+0000' | timeago}} • Announcement

$ABT raised its full year profit forecast backed by the intention of closing the Alere acquisition in 2017. The company raised its FY17 adjusted earnings from continuing operations guidance by $0.03 to a range of $2.43-2.53 per share. Reported EPS forecast was also raised from the range of $0.92-1.02 to $1.03-1.13, reflecting double-digit growth.

$ABT {{ '2017-07-20T17:36:53+0000' | timeago}} • Announcement

Declining operating earnings and rising costs and expenses hit $ABT 2Q17 earnings as much as 54%. Earnings plunged to $283MM or $0.15 from $615MM or $0.40 per share a year earlier. Sales, however, surged 24.4% on St. Jude Medical acquisition. On an adjusted basis, $ABT reported EPS above its previous guidance range at $0.62 per share.

$ABT {{ '2017-07-20T12:52:57+0000' | timeago}} • Infographic

$ABT Abbott Laboratories Earnings AlphaGraphic: Q2 2017 Highlights

$BDX {{ '2017-07-19T13:58:34+0000' | timeago}} • Announcement

$BDX received 510(k) clearance from the FDA for the BD FACSLyric flow cytometer system, an easy-to-use in vitro diagnostic (IVD) system, for use with BD Multitest assays for immunological assessment of individuals and patients having or suspected of having immune deficiency.

$LTXB {{ '2017-07-19T12:21:26+0000' | timeago}} • Announcement

$LTXB, the holding company for LegacyTexas Bank, declared a quarterly cash dividend of $0.15 per share, payable on Aug. 14, 2017, to stockholders of record as of the close of business on July 31, 2017.

$GS {{ '2017-07-19T11:22:37+0000' | timeago}} • Webcast

$GS advised a number of important transactions that were announced during 2Q17, including $BCR's $24Bil sale to $BDX. $AMZN's $13.7Bil acquisition of $WFM, and $DFT's $7.6Bil merger with $DLR.

$BAX {{ '2017-07-18T14:01:55+0000' | timeago}} • Announcement

The BoD of $BAX declared a quarterly dividend of $0.16 per share of its common stock. The dividend is payable on Oct 2, 2017, to stockholders of record as of Sept 1, 2017.

$BAX {{ '2017-07-17T20:58:53+0000' | timeago}} • Announcement

$BAX appointed Cathy Smith, EVP and CFO of $TGT, to its BoD, bringing the total number of directors serving the company at this time to 13. Smith now also serves on $BAX's Audit Committee.

$ABT {{ '2017-07-17T12:36:21+0000' | timeago}} • Announcement

$ABT is commencing a tender offer to purchase for cash all outstanding shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. at a price of $402 per share of Preferred Stock. The offer will expire at 11:59 pm, NYC time, on Aug 11, 2017. There is no financing condition to the offer.

$ABT {{ '2017-07-13T12:23:21+0000' | timeago}} • Announcement

$ABT and Bigfoot Biomedical agreed to develop and commercialize diabetes management systems, integrating $ABT's FreeStyle Libre glucose sensing technology with Bigfoot's insulin delivery solutions in the United States. $ABT will provide Bigfoot with the next generation of its FreeStyle Libre glucose sensing technology.

$LCII {{ '2017-07-03T14:37:19+0000' | timeago}} • Announcement

Engineering firm $LCII said its Lippert Components units acquired Italy-based Metallarte and its subsidiary RV Doors, a manufacturer of driver-side doors. The $16.8MM purchase price was paid from available cash, borrowings under the company's $200MM line of credit and contingent consideration based on future sales.

$ABT {{ '2017-06-29T17:53:11+0000' | timeago}} • Announcement

$ABT announced the Health Canada license of its FreeStyle Libre Flash Glucose Monitoring System, a glucose sensing technology for adults with diabetes. This system eliminates the need for routine finger sticks or finger stick calibration, and reads glucose levels through a sensor that can be worn on the back of the upper arm for up to 14 days.

$BAX {{ '2017-06-26T13:13:55+0000' | timeago}} • Announcement

$BAX has announced a bi-directional integration between its software solution DoseEdge Pharmacy Workflow Manager and the Epic Willow Inpatient Pharmacy System. The integration will help hospitals efficiently comply with requirements from the Centers for Medicare and Medicaid Services and other insurers.

$HYH {{ '2017-06-23T14:47:24+0000' | timeago}} • Announcement

$HYH said Robert Abernathy will retire as CEO, effective June 26, 2017. The BoD has appointed Joseph Woody to succeed Abernathy. Woody has also been elected to serve on the board and Abernathy will continue as chairman of the board.

$SYK {{ '2017-06-19T12:28:25+0000' | timeago}} • Announcement

$SYK agreed to buy $NVDQ. The transaction is expected to be dilutive to $SYK's 2017 adjusted EPS by $0.03-0.05. There is no change in $SYK's 2017 adjusted EPS forecast of $6.35-6.45. For 2018, this transaction is expected to be neutral to $SYK's earnings and accretive thereafter.

$SYK {{ '2017-06-19T12:26:47+0000' | timeago}} • Announcement

$SYK agreed to buy $NVDQ for $11.75 per share, or $701MM with a net purchase price of $654MM, reflecting net cash of about $47MM. The transaction is expected to close at the end of 3Q17.

$ABT {{ '2017-06-16T10:42:39+0000' | timeago}} • Announcement

$ABT announced that the Sekisui CP3000 coagulation system, a fully automated analyzer that tests bleeding and clotting function in blood, is now available in Europe, the Middle East, and Asia Pacific.

Recent Transcripts

ABT (Abbott Laboratories)
Thursday, July 20 2017 - 1:00pm
LTXB (LegacyTexas Financial Group Inc.)
Wednesday, July 19 2017 - 1:00pm
GOOS (Canada Goose Holdings Inc.)
Friday, June 2 2017 - 1:00pm
PUMP (ProPetro Holding Corp.)
Thursday, May 11 2017 - 1:00pm
AYX (Alteryx, Inc.)
Wednesday, May 10 2017 - 9:00pm
PI (Impinj, Inc.)
Thursday, May 4 2017 - 9:00pm
MULE (MuleSoft, Inc.)
Thursday, May 4 2017 - 9:00pm
LCII (LCI Industries)
Thursday, May 4 2017 - 3:00pm
PCRX (Pacira Pharmaceuticals, Inc.)
Thursday, May 4 2017 - 12:30pm
TFX (Teleflex Incorporated)
Thursday, May 4 2017 - 12:00pm
BDX (Becton, Dickinson and Company)
Thursday, May 4 2017 - 12:00pm
HYH (Halyard Health, Inc.)
Tuesday, May 2 2017 - 1:00pm
BDX (Becton, Dickinson and Company)
Tuesday, May 2 2017 - 12:00pm
CAH (Cardinal Health, Inc.)
Monday, May 1 2017 - 12:30pm
CAA (CalAtlantic Group, Inc.)
Friday, April 28 2017 - 3:00pm
BSX (Boston Scientific Corporation)
Thursday, April 27 2017 - 12:00pm
BAX (Baxter International Inc.)
Wednesday, April 26 2017 - 12:30pm
SYK (Stryker Corporation)
Tuesday, April 25 2017 - 8:30pm
LTXB (LegacyTexas Financial Group Inc.)
Wednesday, April 19 2017 - 1:00pm
ABT (Abbott Laboratories)
Wednesday, April 19 2017 - 1:00pm

AlphaGraphics you may like